CHEMBL153

GPTKB entity

Statements (50)
Predicate Object
gptkbp:instanceOf gptkb:chemical_compound
gptkbp:approvalYear 1976
gptkbp:ATCCode gptkb:C07AB03
gptkbp:bioavailability 50% (oral)
gptkbp:CASNumber gptkb:29122-68-7
gptkbp:color white
gptkbp:contraindication asthma
heart block
severe bradycardia
gptkbp:drugClass selective beta-1 blocker
gptkbp:excretion gptkb:kidney
gptkbp:halfLife 6-7 hours
gptkbp:hasInChIKey METKIMKYRPQLGS-UHFFFAOYSA-N
gptkbp:hasLogP 0.16
gptkbp:hasMolecularFormula C14H22N2O3
gptkbp:hasPhysicalForm gptkb:stone
gptkbp:haspKa 9.6
gptkbp:hasSMILES CC(C)NCC(CO)Oc1ccc(cc1)CC(=O)N
gptkbp:hasTherapeuticUse antianginal agent
antiarrhythmic agent
antihypertensive agent
gptkbp:hasUNII 50VV3VW0TI
https://www.w3.org/2000/01/rdf-schema#label CHEMBL153
gptkbp:isApprovedDrug true
gptkbp:legalStatus prescription only
off-patent
gptkbp:listedOn gptkb:WHO_Model_List_of_Essential_Medicines
gptkbp:mechanismOfAction beta-1 adrenergic receptor antagonist
gptkbp:meltingPoint 152-155°C
gptkbp:metabolism liver
gptkbp:molecularWeight 266.34
gptkbp:name gptkb:Atenolol
gptkbp:pregnancyCategory C (US)
gptkbp:PubChem_CID 2162
CHEBI:2269
DB00335
gptkbp:routeOfAdministration oral
intravenous
gptkbp:sideEffect dizziness
fatigue
bradycardia
cold extremities
gptkbp:solubility water soluble
gptkbp:synonym gptkb:Atenololum
gptkb:Tenormin
4-(2-Hydroxy-3-isopropylaminopropoxy)phenylacetamide
gptkbp:target ADRB1_HUMAN
ADRB2_HUMAN
gptkbp:bfsParent gptkb:acetone
gptkbp:bfsLayer 7